AAAAAA
Results:
1-10
|
Results: 10
Authors:
Kopelman, PG
Finer, N
Citation: Pg. Kopelman et N. Finer, Reply: Is obesity a disease?, INT J OBES, 25(10), 2001, pp. 1405-1406
Authors:
Kesaniemi, YA
Danforth, E
Jensen, MD
Kopelman, PG
Lefebvre, P
Reeder, BA
Citation: Ya. Kesaniemi et al., Dose-response issues concerning physical activity and health: an evidence-based symposium, MED SCI SPT, 33(6), 2001, pp. S351-S358
Authors:
Finer, N
James, WPT
Kopelman, PG
Lean, MEJ
Williams, G
Citation: N. Finer et al., One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor, INT J OBES, 24(3), 2000, pp. 306-313
Authors:
Kopelman, PG
Citation: Pg. Kopelman, Physiopathology of prolactin secretion in obesity, INT J OBES, 24, 2000, pp. S104-S108
Authors:
Kopelman, PG
Citation: Pg. Kopelman, Obesity as a medical problem, NATURE, 404(6778), 2000, pp. 635-643
Authors:
Cassell, PG
Saker, PJ
Huxtable, SJ
Kousta, E
Jackson, AE
Hattersley, AT
Frayling, TM
Walker, M
Kopelman, PG
Ramachandran, A
Snehelatha, C
Hitman, GA
McCarthy, MI
Citation: Pg. Cassell et al., Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin, DIABETOLOG, 43(12), 2000, pp. 1558-1564
Authors:
Diemel, LT
Cai, F
Anand, P
Warner, G
Kopelman, PG
Fernyhough, P
Tomlinson, DR
Citation: Lt. Diemel et al., Increased nerve growth factor mRNA in lateral calf skin biopsies from diabetic patients, DIABET MED, 16(2), 1999, pp. 113-118
Authors:
Kopelman, PG
Citation: Pg. Kopelman, Is the hypothalamic-pituitary-adrenal axis really hyperactivated in visceral obesity?, J ENDOC INV, 22(1), 1999, pp. 76-79
Authors:
Kopelman, PG
Citation: Pg. Kopelman, Obesity, TYPE 2 DIABETES, 1999, pp. 193-207
Authors:
Kopelman, PG
Hitman, GA
Citation: Pg. Kopelman et Ga. Hitman, Diabetes - Exploding type II, LANCET, 352, 1998, pp. 5-5
Risultati:
1-10
|